Table 3.
Laboratory parameters of forty-two COVID-19 patients and forty-three non-COVID-19 patients with acute respiratory distress syndrome.
| Laboratory parameters | COVID-19 patients (n = 42) | Non-COVID-19 patients (n = 43) | P-value |
|---|---|---|---|
| Creatinine (mg/dl, normal: 0.6–1.2) | 1.05 ± 0.03 | 1.21 ± 0.05 | 0.02* |
| White blood cells (cells/mm3, normal: 4–10) | 13.1 ± 3.5 | 13.2 ± 2.9 | 0.84 |
| Lymphocytes (109/l, normal: 1.1–3.2) | 0.5 ± 0.2 | 1.5 ± 0.4 | 0.001* |
| White blood cells/lymphocytes ratio | 29.7 ± 2.44 | 11.6 ± 1.46 | 0.001* |
| Platelets (cells/mm3, normal: 150–450) | 134.5 ± 32.7 | 156.8 ± 40.8 | 0.007* |
| International normalization ratio (normal: 0.8–1.2) | 1.19 ± 0.30 | 1.22 ± 0.35 | 0.70 |
| D-Dimers (mcg/ml, normal: <1) | 3.6 ± 0.35 | 0.76 ± 0.11 | 0.001* |
| Total bilirubin (μmol/L, normal: 0 to 26) | 31.3 ± 1.10 | 36.4 ± 0.96 | 0.001* |
| C-reactive protein (mg/L, normal: 0–5) | 127.3 ± 15.75 | 76.4 ± 18.86 | 0.04* |
| Lactate dehydrogenase (u/L, normal: 100–190) | 575.9 ± 57.64 | 233.4 ± 12.86 | 0.001* |
| Ferritin (ng/ml, normal: 23–336) | 589.1 ± 65.5 | 190.8 ± 9.94 | 0.001* |
| Interleukin-6 (pg/ml, normal: 1–7) | 353.3 ± 75.56 | 16.9 ± 6.26 | 0.001* |
*
P-values ≤ 0.05 were statistically significant (comparisons between the COVID-19 vs. the non-COVID-19 group of patients).